Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

China Biologic Produ (CBPO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

China Biologic Produ 18TH FL JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD CHAOYANG DISTRICT BEIJING F4 100125 CHN

P: 86-10-6598-3111 F: 106-598-3222

Description:

China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.

Key Statistics

Overview:

Market Capitalization, $K 3,607,133
Shares Outstanding, K 39,362
Annual Sales, $ 466,880 K
Annual Net Income, $ 128,060 K
Last Quarter Sales, $ 129,780 K
Last Quarter Net Income, $ 37,690 K
60-Month Beta 1.28
% of Insider Shareholders 2.73%
% of Institutional Shareholders 36.29%
Float, K 38,287
% Float 97.27%

Growth:

1-Year Return 16.19%
3-Year Return -21.94%
5-Year Return 102.21%
5-Year Revenue Growth 129.58%
5-Year Earnings Growth 105.10%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.76 on 03/06/19
Next Earnings Date 05/10/19
Earnings Per Share ttm 4.00
EPS Growth vs. Prev Qtr 46.05%
EPS Growth vs. Prev Year -8.26%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

CBPO Ratios

Ratio
Price/Earnings ttm 23.00
Price/Earnings forward 21.42
Price/Earnings to Growth 4.76
Return-on-Equity (After Tax) 8.81
Return-on-Assets (Before Tax) 8.04
Profit Margin % 27.43
Net Margin % 20.95
Debt/Equity 0.00
Price/Sales 7.76
Price/Cash Flow 18.02
Price/Book 1.92
Book Value/Share 47.84
Interest Coverage 489.24
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar